A phase I single- and multiple-ascending doses trial of AM 125 in healthy subjects.
Phase of Trial: Phase I
Latest Information Update: 20 Jul 2017
At a glance
- Drugs Betahistine (Primary)
- Indications Otitis
- Focus Adverse reactions; Pharmacokinetics
- 20 Jul 2017 According to an Auris Medical media release, outcomes from this study will inform dose selection and regimen for a subsequent Phase 2 proof-of-concept trial.
- 20 Jul 2017 According to an Auris Medical media release, the company plans to initiate this trial in the fourth quarter of 2017.
- 21 Mar 2017 New trial record